Don’t wait for weight loss.

Add ENTYCE® (capromorelin oral solution) at the first sign of decreased eating as part of your overall treatment plan.

WHY INTERVENE EARLY?

Don’t wait for weight loss.

WITH REDUCED APPETITE, THERE’S MORE THAN MEETS THE EYE

Add ENTYCE® (capromorelin oral solution) at the first sign of decreased eating as part of your overall treatment plan.

WHY INTERVENE EARLY?

Why ENTYCE?

Stimulate appetite early with ENTYCE as part of an overall treatment plan.

Proven to safely and effectively simulate appetite1,2

Demonstrated a significant increase in food consumption1

Proven safe for long-term use2

Convenient, once-daily dosing

How Entyce Works

Appetite Is a Key Indicator of Quality of Life

It is important to ask pet owners about any changes in their dog’s eating behavior.

  • Reduced appetite is often the first sign — and may be the only sign — a dog is sick or has an underlying medical condition.
  • Changes in eating behavior often trigger a call or visit to the veterinarian.
  • Pet owners consider inappetence, weight loss and depression as unacceptable.3
  • Owners of dogs with chronic medical conditions are distressed by the effects of reduced appetite, often perceiving their pet as suffering.

Efficacy

Results from the Clinical Field Study and Laboratory Effectiveness Study demonstrated increased appetite in dogs receiving ENTYCE versus placebo.

See the result

Safety

Results of the 12-Month Laboratory Safety Study and Clinical Field Study showed ENTYCE is well-tolerated in dogs.

View the Data

Dosing and Administration

ENTYCE provides a convenient, once-daily oral solution for treating reduced appetite in dogs.

Calculate Dosing

References:

  1. BMC Vet Res. 2017; 13:10.
  2. Zollers B, Huebner M, Armintrout G, Rausch-Derra LC, Rhodes L. Evaluation of the safety in dogs of long-term, daily oral administration of capromorelin, a novel drug for stimulation of appetite. J Vet Pharmacol Ther. 2017 Jun;40(3):248-255.
  3. Williams J, Phillips C, Byrd HM. Factors Which Influence Owners When Deciding to Use Chemotherapy in Terminally Ill Pets. Animals (Basel). 2017;7(3):E18.